Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
21.34
+0.36 (1.72%)
Feb 3, 2026, 4:00 PM EST - Market closed
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $1.79 billion as of February 4, 2026. Its market cap has increased by 455.33% in one year.
Market Cap
1.79B
Enterprise Value
1.72B
1-Year Change
455.33%
Ranking
Category
Stock Price
$21.34
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $1.79B, an increase of 514.72%. That is a compound annual growth rate of 20.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.59B | 177.12% |
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 1.88B |
| Syndax Pharmaceuticals | 1.85B |
| Zai Lab | 1.83B |
| Ocular Therapeutix | 1.81B |
| Pharvaris | 1.80B |
| RAPT Therapeutics | 1.79B |
| Definium Therapeutics | 1.76B |
| MBX Biosciences | 1.76B |